Advertisement

Topics

BWXT Announces Strategic Acquisition of Sotera Health’s Nordion Medical Isotope Business

06:45 EDT 17 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
BWX Technologies, Inc. (NYSE:BWXT) (“BWXT” or the “Company”) announced today that it has signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope business. The acquisition accelerates a...

Other Sources for this Article

BWX Technologies, Inc.
Media Contacts:
United States
Jud Simmons, 434-522-6462
Director, Media & Public Relations
hjsimmons@bwxt.com
or
Canada
Natalie Cutler, 519-620-5288
Communications Manager
nacutler@bwxt.com
or
Investor Contact:
Alan Nethery, 980-365-4300
Vice President and Chief Investor Relations Officer
investors@bwxt.com

NEXT ARTICLE

More From BioPortfolio on "BWXT Announces Strategic Acquisition of Sotera Health’s Nordion Medical Isotope Business"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...